FDA orders 23andMe to stop selling genetic tests

23andMe has been advertising that its tests offer diagnostic information for a variety of human conditions.

23andMe, the pioneering genetic screening service, has been told by the FDA that it “must immediately discontinue” marketing of its Personal Genome Service (PGS) until it receives FDA authorization.

 

 

Continue reading… “FDA orders 23andMe to stop selling genetic tests”